Atomic Eagle’s largest shareholder has irrevocably committed to exercise 35.1 million options, giving the uranium developer a potential $10.9 million cash injection before the options expire. The company says the proceeds could fund its Zambia and Niger growth strategy through 2028 without near-term equity financing.
- 35.1 million options committed for early exercise at $0.31 each
- Approximately $10.9 million in proceeds expected by 28 October 2026
- Unaudited cash could rise from $12.1 million to $23.0 million
- Around 17.9 million options remain available for future exercise
- Funding is intended to support parallel work in Zambia and Niger
Largest shareholder commits to $10.9 million exercise
Atomic Eagle Limited (ASX:AEU; OTCQX: AEUXF) has secured a binding funding commitment that could materially extend its runway, with largest shareholder Menel Energy and Resources agreeing to exercise 35,149,113 options at $0.31 each by 28 October 2026. The options are due to expire on 5 May 2027, placing the expected approximately $10.9 million cash injection about six months ahead of schedule.
The proceeds have not yet been received, and the company’s starting cash figure is unaudited. Atomic Eagle says its current cash position is approximately $12.1 million; if Menel completes the exercise, available cash would rise to roughly $23.0 million, compared with about $20 million when the company listed.
Funding gives Zambia and Niger parallel runway
Atomic Eagle says the commitment is expected to provide sufficient funding capacity to pursue its current growth strategy through 2028 without requiring near-term equity financing. Chief executive Phil Hoskins said the additional funding would allow the company to advance its uranium projects in Zambia and Niger in parallel rather than sequentially, although the announcement does not set out a project-by-project spending schedule or specific delivery milestones.
The company’s portfolio centres on the 100%-owned Muntanga Uranium Project in Zambia, which hosts a JORC Mineral Resource of 58.8 million pounds at 309 parts per million U3O8. Atomic Eagle also holds a 60% interest in Niger’s Madaouela project, which has a 116.5 million-pound foreign estimate at 1,282 parts per million U3O8. Those figures describe resources and a foreign estimate, not production or reserves, and the filing provides no new technical results.
Existing options convert, while further funding remains possible
Atomic Eagle describes the exercise as non-dilutive relative to a fresh discounted capital raising because it converts existing on-issue options rather than issuing new securities at a discount. The exercise will nevertheless result in options converting into ordinary shares, so the relevant comparison for shareholders is not simply cash raised but also the resulting increase in issued share capital.
Approximately 17.9 million options in the same category will remain unexercised after Menel’s commitment, with the same $0.31 exercise price and 5 May 2027 expiry. If all were exercised, Atomic Eagle says they could provide a further approximately $5.5 million. The company says most of those options are held by a small number of existing long-term shareholders, leaving a further potential funding source but no disclosed commitment that they will be exercised.
Bottom Line?
The commitment improves Atomic Eagle’s stated funding runway, but the next hard evidence will be settlement of the exercise and how the resulting cash is allocated across its two uranium projects.
Questions in the middle?
- Will Menel complete the option exercise and when will the approximately $10.9 million be received?
- What issued-share increase will follow the conversion, and how will it affect per-share exposure for existing holders?
- Can Atomic Eagle translate the enlarged cash balance into measurable development milestones at Muntanga and Madaouela through 2028?